Terumo (OTCMKTS:TRUMY) Shares Gap Down – What’s Next?
by Scott Moore · The Cerbat GemTerumo Corp. (OTCMKTS:TRUMY – Get Free Report)’s stock price gapped down before the market opened on Friday . The stock had previously closed at $14.68, but opened at $14.1101. Terumo shares last traded at $14.6050, with a volume of 4,997 shares traded.
Terumo Stock Performance
The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.46 and a current ratio of 2.51. The company has a market capitalization of $21.63 billion, a P/E ratio of 24.35 and a beta of 0.75. The business has a 50 day moving average of $15.60 and a 200-day moving average of $16.79.
Terumo (OTCMKTS:TRUMY – Get Free Report) last issued its earnings results on Wednesday, November 12th. The company reported $0.16 EPS for the quarter, hitting the consensus estimate of $0.16. Terumo had a return on equity of 9.39% and a net margin of 12.35%.The business had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.75 billion.
Terumo Company Profile
Terumo Corporation (OTCMKTS: TRUMY) is a Japan-based medical technology company that develops, manufactures and markets a broad range of healthcare products for hospitals, clinics and blood centers. Its businesses encompass cardiovascular systems, general hospital products and blood management and cell technologies, supplying devices used in interventional and surgical procedures as well as everyday clinical care. Terumo sells consumables and capital equipment intended to support patient care across acute and ambulatory settings.
Key product categories include vascular access and interventional devices (such as guidewires, catheters and delivery systems), cardiac and cardiopulmonary surgical equipment, infusion therapy products (including infusion pumps and disposables), syringes and blood bags.